Your browser doesn't support javascript.
loading
Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies.
Macarrón Palacios, Arturo; Grzeschik, Julius; Deweid, Lukas; Krah, Simon; Zielonka, Stefan; Rösner, Thies; Peipp, Matthias; Valerius, Thomas; Kolmar, Harald.
Affiliation
  • Macarrón Palacios A; Institute for Organic Chemistry and Biochemistry, Technische Universität Darmstadt, Darmstadt, Germany.
  • Grzeschik J; Institute for Organic Chemistry and Biochemistry, Technische Universität Darmstadt, Darmstadt, Germany.
  • Deweid L; Institute for Organic Chemistry and Biochemistry, Technische Universität Darmstadt, Darmstadt, Germany.
  • Krah S; Institute for Organic Chemistry and Biochemistry, Technische Universität Darmstadt, Darmstadt, Germany.
  • Zielonka S; Institute for Organic Chemistry and Biochemistry, Technische Universität Darmstadt, Darmstadt, Germany.
  • Rösner T; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, UKSH, CAU Kiel, Kiel, Germany.
  • Peipp M; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, UKSH, CAU Kiel, Kiel, Germany.
  • Valerius T; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, UKSH, CAU Kiel, Kiel, Germany.
  • Kolmar H; Institute for Organic Chemistry and Biochemistry, Technische Universität Darmstadt, Darmstadt, Germany.
Front Immunol ; 11: 560244, 2020.
Article in En | MEDLINE | ID: mdl-33324393
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sharks / Recombinant Fusion Proteins / Antibodies, Anti-Idiotypic / Antineoplastic Agents, Immunological / Antibody Specificity Type of study: Clinical_trials / Prognostic_studies Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2020 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sharks / Recombinant Fusion Proteins / Antibodies, Anti-Idiotypic / Antineoplastic Agents, Immunological / Antibody Specificity Type of study: Clinical_trials / Prognostic_studies Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2020 Document type: Article